| scholarly article | Q13442814 |
| P356 | DOI | 10.1148/RADIOLOGY.171.2.2539609 |
| P698 | PubMed publication ID | 2539609 |
| P50 | author | Michael P. Whyte | Q89919619 |
| William A. Murphy | Q99232778 | ||
| P2093 | author name string | Siegel BA | |
| Reid IR | |||
| Hardy DC | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 403-414 | |
| P577 | publication date | 1989-05-01 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features | |
| P478 | volume | 171 |
| Q41959145 | Ablation of systemic phosphate-regulating gene fibroblast growth factor 23 (Fgf23) compromises the dentoalveolar complex |
| Q46293661 | An atypical degenerative osteoarthropathy in Hyp mice is characterized by a loss in the mineralized zone of articular cartilage |
| Q92340962 | Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial |
| Q36129809 | Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease |
| Q36129867 | Conventional Therapy in Adults With XLH Improves Dental Manifestations, But Not Enthesopathy |
| Q37507342 | Disorders of phosphate homeostasis and tissue mineralisation |
| Q34061540 | Disorders of phosphate metabolism. |
| Q37348702 | Dmp1 Null Mice Develop a Unique Osteoarthritis-like Phenotype |
| Q37092161 | Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia |
| Q47268178 | FGF2 High Molecular Weight Isoforms Contribute to Osteoarthropathy in Male Mice |
| Q90624325 | FGF23 and Associated Disorders of Phosphate Wasting |
| Q64040255 | FGF23 and its role in X-linked hypophosphatemia-related morbidity |
| Q36360389 | Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications |
| Q34579718 | High bone mineral apparent density in children with X-linked hypophosphatemia. |
| Q68256441 | Hypophosphataemic rickets and pyrophosphate arthropathy |
| Q34436396 | Hypophosphatemic rickets |
| Q68130803 | Increased long-bone periosteal/cortical uptake in skeletal scintigraphy |
| Q36439625 | Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice |
| Q37160599 | Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets |
| Q51318721 | PHEX 3'-UTR c.*231A>G near the polyadenylation signal is a relatively common, mild, American mutation that masquerades as sporadic or X-linked recessive hypophosphatemic rickets. |
| Q37732777 | Patients with Hypophosphatemic Osteomalacia Need Continuous Treatment during Adulthood |
| Q57727161 | Phenotype Presentation of Hypophosphatemic Rickets in Adults |
| Q54203140 | Phosphate transport in osteoblasts from normal and X-linked hypophosphatemic mice. |
| Q38062365 | Rickets: Part II. |
| Q64906771 | The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey. |
| Q40725847 | Therapeutics of X-linked hypophosphatemic rickets |
| Q35848808 | X-linked hypophosphataemia: a homologous phenotype in humans and mice with unusual organ-specific gene dosage |
Search more.